{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T09:58:43Z","timestamp":1768903123035,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.virusres.2022.198816","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T13:27:22Z","timestamp":1652966842000},"page":"198816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["In-vitro antiviral activity of doxepin hydrochloride against group B coxsackievirus"],"prefix":"10.1016","volume":"317","author":[{"given":"Yongqi","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ge","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaoyan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinchang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2022.198816_bib0001","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ejmech.2012.01.022","article-title":"Efficient synthesis and anti-enteroviral activity of 9-arylpurines","volume":"49","author":"Aguado","year":"2012","journal-title":"Eur J Med Chem"},{"issue":"6","key":"10.1016\/j.virusres.2022.198816_bib0002","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00430-015-0391-4","article-title":"The anti-obesity drug orlistat reveals anti-viral activity","volume":"204","author":"Ammer","year":"2015","journal-title":"Med. Microbiol. Immunol."},{"issue":"2","key":"10.1016\/j.virusres.2022.198816_bib0003","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jdcr.2017.01.026","article-title":"Coxsackievirus B5 associated with hand-foot-mouth disease in a healthy adult","volume":"3","author":"Andreoni","year":"2017","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.virusres.2022.198816_bib0004","first-page":"51","article-title":"The role of Coxsackie B viruses in the pathogenesis of myocarditis, dilated cardiomyopathy and inflammatory muscle disease","volume":"53","author":"Archard","year":"1987","journal-title":"Biochem. Soc. Symp."},{"key":"10.1016\/j.virusres.2022.198816_bib0005","first-page":"31","article-title":"Coxsackie B viruses and human heart disease","volume":"223","author":"Baboonian","year":"1997","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.virusres.2022.198816_bib0006","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.antiviral.2018.10.002","article-title":"Fluoxetine can inhibit coxsackievirus-B4 E2 in vitro and in vivo","volume":"159","author":"Benkahla","year":"2018","journal-title":"Antiviral Res."},{"issue":"3","key":"10.1016\/j.virusres.2022.198816_bib0007","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11916-017-0615-y","article-title":"Topical treatments for localized neuropathic pain","volume":"21","author":"Casale","year":"2017","journal-title":"Curr. Pain Headache Rep."},{"issue":"5","key":"10.1016\/j.virusres.2022.198816_bib0008","first-page":"384","article-title":"Coxsackievirus infection associated with acute pancreatitis","volume":"5","author":"Chrysos","year":"2004","journal-title":"JOP: J. pancreas"},{"key":"10.1016\/j.virusres.2022.198816_bib0009","first-page":"1","article-title":"A short history and introductory background on the coxsackieviruses of group B","volume":"223","author":"Crowell","year":"1997","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"6","key":"10.1016\/j.virusres.2022.198816_bib0010","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1002\/jmv.26747","article-title":"Berberine impairs coxsackievirus B3-induced myocarditis through the inhibition of virus replication and host pro-inflammatory response","volume":"93","author":"Dai","year":"2021","journal-title":"J. Med. Virol."},{"issue":"2","key":"10.1016\/j.virusres.2022.198816_bib0011","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1440-1754.1998.00176.x","article-title":"A cluster of cases of neonatal coxsackievirus B meningitis and myocarditis","volume":"34","author":"Daley","year":"1998","journal-title":"J. Paediatr. Child Health"},{"issue":"2794","key":"10.1016\/j.virusres.2022.198816_bib0012","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1126\/science.108.2794.61","article-title":"An unidentified, filtrable agent isolated from the feces of children with paralysis","volume":"108","author":"Dalldorf","year":"1948","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.virusres.2022.198816_bib0013","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/bjo.77.3.182","article-title":"Coxsackievirus B3-associated panuveitis","volume":"77","author":"F\u00f6rster","year":"1993","journal-title":"Br. J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.virusres.2022.198816_bib0014","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s00705-016-2842-7","article-title":"An epidemic of coxsackievirus B3 infection in infants and children in Jiangsu Province, China: a prospective cohort study","volume":"161","author":"Gao","year":"2016","journal-title":"Arch. Virol."},{"issue":"4","key":"10.1016\/j.virusres.2022.198816_bib0015","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.apsb.2014.06.008","article-title":"The antiviral effect of jiadifenoic acids C against coxsackievirus B3","volume":"4","author":"Ge","year":"2014","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.virusres.2022.198816_bib0016","doi-asserted-by":"crossref","DOI":"10.1177\/2040206620906061","article-title":"Genome analysis of coxsackievirus B1 isolates during the consecutive alternating administration course of triple antiviral combination in newborn mice","volume":"28","author":"Grozdanov","year":"2020","journal-title":"Antivir. Chem. Chemother."},{"issue":"1","key":"10.1016\/j.virusres.2022.198816_bib0017","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1186\/s12879-019-4107-z","article-title":"Two Coxsackievirus B3 outbreaks associated with hand, foot, and mouth disease in China and the evolutionary history worldwide","volume":"19","author":"Han","year":"2019","journal-title":"BMC Infect. Dis."},{"issue":"5","key":"10.1016\/j.virusres.2022.198816_bib0018","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1192\/bjp.bp.109.070219","article-title":"Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose","volume":"196","author":"Hawton","year":"2010","journal-title":"The Br. j. psychiatry: the j. mental sci."},{"issue":"1\u20132","key":"10.1016\/j.virusres.2022.198816_bib0019","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijmm.2007.08.010","article-title":"Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease","volume":"298","author":"Henke","year":"2008","journal-title":"Int. j. med. microbiol.: IJMM"},{"issue":"2","key":"10.1016\/j.virusres.2022.198816_bib0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jinf.2012.03.021","article-title":"Coxsackievirus B5, associated with neurological hand, foot and mouth disease","volume":"65","author":"Hu","year":"2012","journal-title":"China. The J. infect."},{"key":"10.1016\/j.virusres.2022.198816_bib0021","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.antiviral.2017.01.013","article-title":"Oxymatrine provides protection against Coxsackievirus B3-induced myocarditis in BALB\/c mice","volume":"141","author":"Jiang","year":"2017","journal-title":"Antiviral Res."},{"issue":"9","key":"10.1016\/j.virusres.2022.198816_bib0022","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/jphp.13273","article-title":"Drug repositioning: a brief overview","volume":"72","author":"Jourdan","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"10.1016\/j.virusres.2022.198816_bib0023","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.euroneuro.2018.01.007","article-title":"Antidepressants as antipruritic agents: a review","volume":"28","author":"Kaur","year":"2018","journal-title":"Eur. neuropsychopharmacol.: the j. European College of Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.virusres.2022.198816_bib0024","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/00003495-198938010-00005","article-title":"Dothiepin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness","volume":"38","author":"Lancaster","year":"1989","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.virusres.2022.198816_bib0025","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/14737175.2020.1752669","article-title":"Identifying and responding to fatigue and apathy in Parkinson's disease: a review of current practice","volume":"20","author":"Lazcano-Ocampo","year":"2020","journal-title":"Expert Rev. Neurother."},{"issue":"11","key":"10.1016\/j.virusres.2022.198816_bib0026","first-page":"1168","article-title":"Etiology and clinical analysis of central nervous system infection caused by Coxsackievirus B5 in severe hand, foot and mouth disease in Qingdao City, 2013-2014","volume":"52","author":"Liang","year":"2018","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"issue":"10","key":"10.1016\/j.virusres.2022.198816_bib0027","doi-asserted-by":"crossref","first-page":"11842","DOI":"10.3390\/molecules181011842","article-title":"In vitro and in vivo studies of the inhibitory effects of emodin isolated from Polygonum cuspidatum on Coxsakievirus B\u2084","volume":"18","author":"Liu","year":"2013","journal-title":"Molecules"},{"issue":"51","key":"10.1016\/j.virusres.2022.198816_bib0028","doi-asserted-by":"crossref","first-page":"21984","DOI":"10.1073\/pnas.0910040106","article-title":"Target identification using drug affinity responsive target stability (DARTS)","volume":"106","author":"Lomenick","year":"2009","journal-title":"Proceed. Nat. Acad. Sci."},{"issue":"12","key":"10.1016\/j.virusres.2022.198816_bib0029","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.3390\/v7122945","article-title":"Infectious entry pathway of enterovirus B species","volume":"7","author":"Marjomaki","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2022.198816_bib0030","first-page":"53","article-title":"Group B coxsackie disease in children","volume":"223","author":"Modlin","year":"1997","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"2","key":"10.1016\/j.virusres.2022.198816_bib0031","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1128\/JVI.78.2.855-867.2004","article-title":"Evidence for frequent recombination within species human enterovirus B based on complete genomic sequences of all thirty-seven serotypes","volume":"78","author":"Oberste","year":"2004","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.virusres.2022.198816_bib0032","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s12265-015-9659-8","article-title":"Panax notoginseng saponins ameliorates coxsackievirus b3-induced myocarditis by activating the cystathionine-\u03b3-lyase\/hydrogen sulfide pathway","volume":"8","author":"Pan","year":"2015","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"3","key":"10.1016\/j.virusres.2022.198816_bib0033","doi-asserted-by":"crossref","first-page":"e90379","DOI":"10.1371\/journal.pone.0090379","article-title":"New coxsackievirus B4 genotype circulating in Inner Mongolia autonomous region","volume":"9","author":"Tian","year":"2014","journal-title":"China. PloS one"},{"key":"10.1016\/j.virusres.2022.198816_bib0034","article-title":"Enterovirus A71 antivirals: past, present, and future","author":"Wang","year":"2021","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"1","key":"10.1016\/j.virusres.2022.198816_bib0035","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1142\/S0192415X20500081","article-title":"Baicalin inhibits Coxsackievirus B3 replication by reducing cellular lipid synthesis","volume":"48","author":"Wang","year":"2020","journal-title":"Am. J. Chin. Med. (Gard City N Y)"},{"issue":"3","key":"10.1016\/j.virusres.2022.198816_bib0036","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0163-4453(98)92076-X","article-title":"Fatal coxsackievirus B infection in early infancy characterized by fulminant hepatitis","volume":"37","author":"Wang","year":"1998","journal-title":"J. Infect."},{"key":"10.1016\/j.virusres.2022.198816_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104699","article-title":"N-Acetyl cysteine effectively alleviates Coxsackievirus B-Induced myocarditis through suppressing viral replication and inflammatory response","volume":"179","author":"Wang","year":"2020","journal-title":"Antiviral Res."},{"issue":"1","key":"10.1016\/j.virusres.2022.198816_bib0038","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4149\/av_2021_106","article-title":"In vitro and in vivo antiviral activity of a fluoronucleoside analog, NCC, against Coxsackie virus B3","volume":"65","author":"Wang","year":"2021","journal-title":"Acta Virol."},{"issue":"2","key":"10.1016\/j.virusres.2022.198816_bib0039","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.antiviral.2009.08.004","article-title":"Phyllaemblicin B inhibits Coxsackie virus B3 induced apoptosis and myocarditis","volume":"84","author":"Wang","year":"2009","journal-title":"Antiviral Res."},{"issue":"4","key":"10.1016\/j.virusres.2022.198816_bib0040","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3892\/etm.2015.2686","article-title":"Efficacy and safety evaluation of citalopram and doxepin on sleep quality in comorbid insomnia and anxiety disorders","volume":"10","author":"Wu","year":"2015","journal-title":"Exp. Ther. Med."},{"issue":"8","key":"10.1016\/j.virusres.2022.198816_bib0041","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1080\/10286020.2019.1642329","article-title":"Luteolin inhibits CVB3 replication through inhibiting inflammation","volume":"22","author":"Wu","year":"2020","journal-title":"J. Asian Nat. Prod. Res."},{"issue":"9","key":"10.1016\/j.virusres.2022.198816_bib0042","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1128\/JCM.00270-13","article-title":"Recombinant human coxsackievirus B3 from children with acute myocarditis in China","volume":"51","author":"Wu","year":"2013","journal-title":"J. Clin. Microbiol."},{"issue":"8","key":"10.1016\/j.virusres.2022.198816_bib0043","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1007\/s00705-021-05128-5","article-title":"Coxsackievirus B4: an underestimated pathogen associated with a hand, foot, and mouth disease outbreak","volume":"166","author":"Xiao","year":"2021","journal-title":"Arch. Virol."},{"issue":"9","key":"10.1016\/j.virusres.2022.198816_bib0044","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00204-20","article-title":"The pyrimidine analog FNC potently inhibits the replication of multiple enteroviruses","volume":"94","author":"Xu","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2022.198816_bib0045","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jcv.2015.01.013","article-title":"Effect of intravenous immunoglobulin for neonates with severe enteroviral infections with emphasis on the timing of administration","volume":"64","author":"Yen","year":"2015","journal-title":"J. clinical virol.: the official publication of the Pan Am. Society for Clin. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2022.198816_bib0046","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00705-016-3075-5","article-title":"Molecular characterization of a new human coxsackievirus B2 associated with severe hand-foot-mouth disease in Yunnan Province of China in 2012","volume":"162","author":"Zhang","year":"2017","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virusres.2022.198816_bib0047","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.antiviral.2017.02.018","article-title":"Umifenovir effectively inhibits IL-10 dependent persistent Coxsackie B4 virus infection","volume":"141","author":"Zhang","year":"2017","journal-title":"Antiviral Res."},{"issue":"6","key":"10.1016\/j.virusres.2022.198816_bib0048","doi-asserted-by":"crossref","first-page":"e67157","DOI":"10.1371\/journal.pone.0067157","article-title":"Epidemics and frequent recombination within species in outbreaks of human enterovirus B-associated hand, foot and mouth disease in Shandong China in 2010 and 2011","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.virusres.2022.198816_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104169","article-title":"Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication","volume":"144","author":"Zhao","year":"2020","journal-title":"Microb. Pathog."},{"issue":"3","key":"10.1016\/j.virusres.2022.198816_bib0050","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ejps.2011.08.030","article-title":"Inhibition of enterovirus 71 replication by chrysosplenetin and penduletin","volume":"44","author":"Zhu","year":"2011","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170222001435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170222001435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:17:14Z","timestamp":1759155434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170222001435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":50,"alternative-id":["S0168170222001435"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2022.198816","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-vitro antiviral activity of doxepin hydrochloride against group B coxsackievirus","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2022.198816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"198816"}}